Tuo X - Search Results

1

20(S)-Rg3 upregulates FDFT1 via reducing miR-4425 to inhibit ovarian cancer progression.

Lu J, Zhou Y, Zheng X, Chen L, Tuo X, Chen H, Xue M, Chen Q, Chen W, Li X, Zhao L. Lu J, et al. Among authors: tuo x. Arch Biochem Biophys. 2020 Oct 30;693:108569. doi: 10.1016/j.abb.2020.108569. Epub 2020 Sep 1. Arch Biochem Biophys. 2020. PMID: 32877662

2

Human Papillomavirus Oncogene Manipulation Using Clustered Regularly Interspersed Short Palindromic Repeats/Cas9 Delivered by pH-Sensitive Cationic Liposomes.

Zhen S, Liu Y, Lu J, Tuo X, Yang X, Chen H, Chen W, Li X. Zhen S, et al. Among authors: tuo x. Hum Gene Ther. 2020 Mar;31(5-6):309-324. doi: 10.1089/hum.2019.312. Epub 2020 Feb 19. Hum Gene Ther. 2020. PMID: 31973584

3

Enhanced antiviral benefit of combination therapy with anti-HBV and anti-PD1 gRNA/cas9 produces a synergistic antiviral effect in HBV infection.

Zhen S, Qiang R, Lu J, Tuo X, Yang X, Li X. Zhen S, et al. Among authors: tuo x. Mol Immunol. 2021 Feb;130:7-13. doi: 10.1016/j.molimm.2020.12.004. Epub 2020 Dec 16. Mol Immunol. 2021. PMID: 33340931

4

TGF-β1-based CRISPR/Cas9 Gene Therapy Attenuates Radiation-induced Lung Injury.

Zhen S, Qiang R, Lu J, Tuo X, Yang X, Li X. Zhen S, et al. Among authors: tuo x. Curr Gene Ther. 2022;22(1):59-65. doi: 10.2174/1566523220666201230100523. Curr Gene Ther. 2022. PMID: 33380298

5

Downregulation of DNMT3A Attenuates the Warburg Effect, Proliferation, and Invasion via Promoting the Inhibition of miR-603 on HK2 in Ovarian Cancer.

Lu J, Zhen S, Tuo X, Chang S, Yang X, Zhou Y, Chen W, Zhao L, Li X. Lu J, et al. Among authors: tuo x. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221110668. doi: 10.1177/15330338221110668. Technol Cancer Res Treat. 2022. PMID: 35770296 Free PMC article.

6

miR-532-3p suppresses proliferation and invasion of ovarian cancer cells via GPNMB/HIF-1α/HK2 axis.

Tuo X, Zhou Y, Yang X, Ma S, Liu D, Zhang X, Hou H, Wang R, Li X, Zhao L. Tuo X, et al. Pathol Res Pract. 2022 Sep;237:154032. doi: 10.1016/j.prp.2022.154032. Epub 2022 Jul 19. Pathol Res Pract. 2022. PMID: 35914373

7

CRISPR/Cas9-HPV-liposome enhances antitumor immunity and treatment of HPV infection-associated cervical cancer.

Zhen S, Qiang R, Lu J, Tuo X, Yang X, Li X. Zhen S, et al. Among authors: tuo x. J Med Virol. 2023 Jan;95(1):e28144. doi: 10.1002/jmv.28144. Epub 2022 Oct 11. J Med Virol. 2023. PMID: 36121194

8

Intravaginal delivery for CRISPR-Cas9 technology: For example, the treatment of HPV infection.

Zhen S, Chen H, Lu J, Yang X, Tuo X, Chang S, Tian Y, Li X. Zhen S, et al. Among authors: tuo x. J Med Virol. 2023 Feb;95(2):e28552. doi: 10.1002/jmv.28552. J Med Virol. 2023. PMID: 36734062 Review.

9

A Novel Germline Mutation of BRCA1 and Integrated Analysis With Somatic Mutation in a Chinese Multi-Cancer Family.

Yang X, Shang L, Yang L, Sun L, Tuo X, Ma S, Zhao L, Li X, Yang W. Yang X, et al. Among authors: tuo x. Oncologist. 2024 Jun 3;29(6):e837-e842. doi: 10.1093/oncolo/oyad294. Oncologist. 2024. PMID: 38159086 Free PMC article.

10

S100A1 overexpression stimulates cell proliferation and is predictive of poor outcome in ovarian cancer.

Jin W, Hui H, Jiang J, Li B, Deng Z, Tuo X. Jin W, et al. Among authors: tuo x. Transl Cancer Res. 2024 Oct 31;13(10):5265-5277. doi: 10.21037/tcr-24-430. Epub 2024 Oct 21. Transl Cancer Res. 2024. PMID: 39525021 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters